← SynDRA
MAVOGLURANT
SynDRA canonical compound SYN0037804 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CYP2C19 | CYP2C8 | GRM5 |
|---|
| Mechanism of action | glutamate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- GRM5 ANTAGONIST
- Metabotropic glutamate receptor 5 antagonist
- glutamate receptor antagonist
- GRM5 MODULATOR
Cross-references
Synonyms
- AFQ-056
- AFQ056
- AFQ 056
- GT0I9SV4F6
- mavoglurantum
- RefChem:155994
- DTXCID60125268
- Mavoglurant racemate
- Mavoglurant [INN]
- Mavoglurant [USAN:INN]
- UNII-GT0I9SV4F6
- MFCD18633263
- 4oo9
- Mavoglurant, AFQ056
- MAVOGLURANT [USAN]
- Mavoglurant (AFQ 056)?
- MAVOGLURANT [WHO-DD]
- orb198441
- SCHEMBL989279
- GTPL7586
- orb1709192
- orb3132236
- SCHEMBL29744485
- ZFPZEYHRWGMJCV-ZHALLVOQSA-N
- GLXC-15608
- EX-A1564
- BDBM50443085
- AKOS027326541
- CS-5245
- T11951L
- AS-79009
- HY-15257
- DB-102250
- NS00069300
- F85319
- F85489
- T11951
- BRD-K07790550-001-01-6
Look up MAVOGLURANT in the interactive SynDRA portal →